Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture

J Clin Rheumatol. 2014 Sep;20(6):347-8. doi: 10.1097/RHU.0000000000000154.
No abstract available

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Density Conservation Agents / therapeutic use*
  • Calcium / administration & dosage
  • Calcium / therapeutic use
  • Dietary Supplements
  • Diphosphonates / therapeutic use
  • Female
  • Follow-Up Studies
  • Fractures, Bone / etiology*
  • France
  • Hip Fractures / etiology*
  • Humans
  • Imidazoles / therapeutic use
  • Male
  • Middle Aged
  • Osteoporosis / complications*
  • Osteoporosis / drug therapy*
  • Osteoporotic Fractures / etiology*
  • Prescriptions / statistics & numerical data*
  • Raloxifene Hydrochloride / therapeutic use
  • Retrospective Studies
  • Thiophenes / therapeutic use
  • Treatment Outcome
  • Vitamin D / administration & dosage
  • Vitamin D / therapeutic use
  • Wrist Injuries / etiology*
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Thiophenes
  • strontium ranelate
  • Vitamin D
  • Raloxifene Hydrochloride
  • Zoledronic Acid
  • Calcium